Evidence map›Paper›PMID 33074356›Full record

ReviewArchives of dermatological research2021

Teledermatology: current indications and considerations for future use.

Jacob Beer, Edward Hadeler, Alejo Calume, Howard Gitlow, Keyvan Nouri

Abstract readReview
In one paragraph

Review in Archives of dermatological research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review of Teledermatology: Lessons Learned from the COVID-19 Pandemic.American journal of clinical dermatology · 2024
    Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Image-based automated Psoriasis Area Severity Index scoring by Convolutional Neural Networks.Journal of the European Academy of Dermatology and Venereology : JEADV · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jacob BeerPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. jacob.beer@pennmedicine.upenn.edu.
Edward HadelerDr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL, USA.
Alejo CalumeMiami Herbert Business School, University of Miami, Miami, FL, USA.
Howard GitlowMiami Herbert Business School, University of Miami, Miami, FL, USA.
Keyvan NouriDr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Telemedicine is one of the most consequential technologies in modern healthcare. In certain situations, it allows for the delivery of care with high quality and minimal difficulty. This is particularly true in dermatology, in which many dermatological conditions can be treated remotely. The burden on dermatology patients has been greatly reduced for certain pathologies due to telemedicine. Health care providers also achieve improved job satisfaction following the convenience of meeting their patients. This paper details select dermatological conditions, and subsequently divides them into those treatable by telemedicine appointments, and those requiring face to face appointments.

Indexed as

Acne VulgarisAftercareDermatitis, AtopicDermatologistsDermatologyHumansJob SatisfactionOffice VisitsPsoriasisRandomized Controlled Trials as TopicSkin NeoplasmsTelemedicineTreatment OutcomeTeledermatologyTelemedicine

Identifiers

PMID33074356
PMCPMC7570421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.